Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil

Human infections with avian-origin influenza A(H7N9) virus represent a serious threat to global health; however, treatment options are limited. Here, we show the inhibitory effects of baloxavir acid (BXA) and its prodrug baloxavir marboxil (BXM), a first-in-class cap-dependent endonuclease inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Keiichi, Ando, Yoshinori, Nobori, Haruaki, Toba, Shinsuke, Noshi, Takeshi, Kobayashi, Masanori, Kawai, Makoto, Yoshida, Ryu, Sato, Akihiko, Shishido, Takao, Naito, Akira, Matsuno, Keita, Okamatsu, Masatoshi, Sakoda, Yoshihiro, Kida, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401108/
https://www.ncbi.nlm.nih.gov/pubmed/30837531
http://dx.doi.org/10.1038/s41598-019-39683-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401108/
https://www.ncbi.nlm.nih.gov/pubmed/30837531
http://dx.doi.org/10.1038/s41598-019-39683-4

Ejemplares similares